Novel Platinum(II) and Platinum(IV) Antitumor Agents that Exhibit Potent Cytotoxicity and Selectivity

A novel platinum­(II) complex 47OMESS­(II) and its platinum­(IV)
derivative 47OMESS­(IV) were synthesized and characterized.
Cytotoxicity studies against mesenchymal cells (MCs) and lung (A549),
breast (MDA-MB-231), and melanoma (A375) cancer cells demonstrated
7–20-fold superior activity for both complexes relative to
cisplatin. Remarkably, 47OMESS­(IV) demonstrated 17–22-fold
greater selectivity toward the cancerous cells compared to the non-cancerous
MCs. Western blot analysis on A549 cells showed the involvement of
the intrinsic apoptotic pathway. Cellular fractionation and uptake
experiments in A549 cells using ICP-mass spectrometry (MS) indicated
that 47OMESS­(II) and 47OMESS­(IV) cross the
cellular membrane predominantly via active transport mechanisms. The
significant improvement in selectivity that is exhibited by 47OMESS­(IV) is reported for the first time for this class
of complexes.